2020年非布司他最新价格

Gout is also called hyperuricemia. Gout is a joint pain disease caused by high uric acid. Uric acid is an excretion. The human body produces uric acid every day and then excretes it through feces and sweat. And if there is too much uric acid, it is easy to deposit, and the main location of deposition is in the joint cavity, so pain occurs. Febuxostat (febuxostat, feburic) is suitable for the long-term treatment of hyperuricemia in patients with gout.

In April 2008, febuxostat (febuxostat, feburic) was approved for marketing in Europe. In February 2009, the FDA approved febuxostat (febuxostat, feburic) for marketing. On June 26, 2013, febuxostat was officially launched in China. Febuxostat (feburic) and allopurinol are both xanthine oxidase inhibitors, but their molecular structures are completely different from allopurinol and purine. They can bind to xanthine oxidase through a non-competitive mechanism, inhibit xanthine enzyme activity, and inhibit the production of uric acid. Moreover, febuxostat not only inhibits the reduced form, but also inhibits the oxidized xanthine oxidase, so a small dose can exert a powerful inhibitory effect on xanthine oxidase. In addition, febuxostat does not interfere with the synthesis of purine and pyrimidine, so it has fewer adverse reactions than allopurinol.

What is the latest price of Febuxostat in 2020?

The price of febuxostat (febuxostat, feburic) on the domestic market is $10 per tablet, 40mg/tablet, and the recommended dosage is 40mg/day, which means it costs about $300 a month. Patients with poor absorption of febuxostat may need to increase the dosage to 80mg/day, which means they need two tablets a day, which costs about $600 a month. Medical Travel has learned that Febuxostat is cheaper in India. The Indian specification is 80mg*30 tablets/box, and its price is about $100. The price in India is about 200$ for 40mg*100 tablets/box. Consult Medical Companion Travel for details.